Compared to women with ER+/PR+ tumors, those with ER-/PR- tumors had increased risks of mortality across almost all histologic classifications, suggesting that combined ER/PR negativity has implications for relative mortality risk, regardless of tumor histology. This evidence concerns the gene ESR1 and neoplasm.